Lauren A. Walter

Country flagUnited States

Research Interests

Explore related searches

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (11)

Year:

2024

Year:

2024

Year:

2023

Hepatitis C virus (HCV) surveillance is a critical component of a comprehensive strategy to prevent and control HCV infection and HCV‐related chronic liver disease. The emergency department (ED) has been increasingly recognized as a vital partner in HCV testing and linkage. We sought to consider active RNA HCV viremia over time in patients participating in an ED‐based testing programme as a measure of local HCV surveillance and as a barometer of ED‐testing programme impact. We performed a retrospective analysis of individuals participating in our ED‐based HCV testing programme between 2015 and 2021. Chi‐square tests were used to compare the demographic characteristics of HCV antibody positive tests with active viremia to those without active viremia. Cox proportional hazard models were used to estimate the trend in active viremia risk over time in the overall study population as well as in key subpopulations of interest. Of 5456 HCV antibody positive individuals, 3102 (56.8%) had active viremia. In the overall study population, we found that the risk of active viremia decreased by 4.8% per year during the study period (RR: 0.95, 95% CI: 0.93–0.97| p < .0001). Baby boomers experienced a 9% decrease in active viremia risk per year over the study period while non‐baby boomers only had a 2% decrease in risk per year ( p = .0009). Compared with insured patients, uninsured patients had a smaller decrease in risk of active HCV viremia per year ( p = .003). No significant differences in the risk of active viremia over time were observed for gender ( p = .4694) or by primary care provider status ( p = .2208). In conclusion, this ED‐based testing and linkage programme demonstrates significantly decreased active HCV viremia over time. It also highlights subpopulations, specifically non‐baby boomers and uninsured patients, who may benefit from focused interventions to improve access to and adoption of definitive HCV care.

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Collaborators (5)

Elizabeth Schoenfeld

Assistant Professor

University of Massachusetts Medical School - Baystate

UNITED STATES
View details

James Crosby

Assistant Professor

University of Alabama, Tuscaloosa

UNITED STATES
View details

Kay Smith

Professor/Senior Research Librarian

The University of Alabama

UNITED STATES
View details

James Booth

Associate Professor

UAB Health System

UNITED STATES
View details

Charles Khoury

The University of Alabama

UNITED STATES
View details
ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.